135 related articles for article (PubMed ID: 36218843)
21. Projecting future drug expenditures--2005.
Hoffman JM; Shah ND; Vermeulen LC; Hunkler RJ; Hontz KM
Am J Health Syst Pharm; 2005 Jan; 62(2):149-67. PubMed ID: 15700889
[TBL] [Abstract][Full Text] [Related]
22. The past, present, and future of basal insulins.
Pettus J; Santos Cavaiola T; Tamborlane WV; Edelman S
Diabetes Metab Res Rev; 2016 Sep; 32(6):478-96. PubMed ID: 26509843
[TBL] [Abstract][Full Text] [Related]
23. By any means necessary: why lowering insulin prices is relevant to racial health equity.
Peek ME
Lancet; 2021 Nov; 398(10313):1783-1784. PubMed ID: 34774134
[No Abstract] [Full Text] [Related]
24. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
Aaserud M; Dahlgren AT; Kösters JP; Oxman AD; Ramsay C; Sturm H
Cochrane Database Syst Rev; 2006 Apr; (2):CD005979. PubMed ID: 16625648
[TBL] [Abstract][Full Text] [Related]
25. The impact of drug pricing policies on the health of the elderly.
Russell LB; Wolff N
Am J Prev Med; 2002 Apr; 22(3):151-5. PubMed ID: 11897458
[TBL] [Abstract][Full Text] [Related]
26. Changing prescribing patterns and increasing prescription expenditures in Medicaid.
Fink KS; Byrns PJ
Ann Fam Med; 2004; 2(5):488-93. PubMed ID: 15506586
[TBL] [Abstract][Full Text] [Related]
27. Lessons learned from trends in psychotropic drug expenditures in a canadian province.
Dewa CS; Goering P
Psychiatr Serv; 2001 Sep; 52(9):1245-7. PubMed ID: 11533401
[TBL] [Abstract][Full Text] [Related]
28. Long-acting insulin analogs versus human insulins.
Garg SK; Naik RG
Diabetes Technol Ther; 2008 Oct; 10(5):331-2. PubMed ID: 18715208
[No Abstract] [Full Text] [Related]
29. Uncontrollable medicine prices in Pakistan.
Saleem F; Hassali MA; Iqbal Q; Baloch M; Shanker PR
Lancet; 2016 Nov; 388(10060):2602. PubMed ID: 27832869
[No Abstract] [Full Text] [Related]
30. Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy.
Haldrup S; Lapolla A; Gundgaard J; Wolden ML
J Med Econ; 2020 Mar; 23(3):271-279. PubMed ID: 31526202
[No Abstract] [Full Text] [Related]
31. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
[TBL] [Abstract][Full Text] [Related]
32. Biosimilar Insulin and Costs: What Can We Expect?
Heinemann L
J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
[TBL] [Abstract][Full Text] [Related]
33. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
[TBL] [Abstract][Full Text] [Related]
34. Prescription drug expenditures rising--too fast?
CMAJ; 2005 May; 172(10):1261, 1263. PubMed ID: 15883389
[No Abstract] [Full Text] [Related]
35. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
36. Insulin Shocks.
White J; Corwin N
J Health Polit Policy Law; 2022 Dec; 47(6):731-753. PubMed ID: 35867535
[TBL] [Abstract][Full Text] [Related]
37. Biosimilar vs originator insulins: Systematic review and meta-analysis.
Yamada T; Kamata R; Ishinohachi K; Shojima N; Ananiadou S; Nom H; Yamauchi T; Kadowaki T
Diabetes Obes Metab; 2018 Jul; 20(7):1787-1792. PubMed ID: 29536603
[TBL] [Abstract][Full Text] [Related]
38. Projecting future drug expenditures--2009.
Hoffman JM; Shah ND; Vermeulen LC; Doloresco F; Martin PK; Blake S; Matusiak L; Hunkler RJ; Schumock GT
Am J Health Syst Pharm; 2009 Feb; 66(3):237-57. PubMed ID: 19179637
[TBL] [Abstract][Full Text] [Related]
39. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis.
Eby EL; Wang P; Curtis BH; Xie J; Haldane DC; Idris I; Peters AL; Hood RC; Jackson JA
J Med Econ; 2013; 16(4):529-38. PubMed ID: 23363330
[TBL] [Abstract][Full Text] [Related]
40. The new insulins. Their characteristics and clinical indications.
Home PD; Alberti KG
Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
